These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18226912

  • 1. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
    Teixeira C, Barbault F, Rebehmed J, Liu K, Xie L, Lu H, Jiang S, Fan B, Maurel F.
    Bioorg Med Chem; 2008 Mar 15; 16(6):3039-48. PubMed ID: 18226912
    [Abstract] [Full Text] [Related]

  • 2. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P, Srinivas E, Raghu R, Sastry GN.
    J Mol Graph Model; 2007 Jul 15; 26(1):378-90. PubMed ID: 17307372
    [Abstract] [Full Text] [Related]

  • 3. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y, Liu H, Niu C, Luo C, Luo X, Shen J, Chen K, Jiang H.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6193-208. PubMed ID: 15519163
    [Abstract] [Full Text] [Related]

  • 4. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
    Yi P, Fang X, Qiu M.
    Eur J Med Chem; 2008 May 01; 43(5):925-38. PubMed ID: 17698256
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors.
    He XY, Zou P, Qiu J, Hou L, Jiang S, Liu S, Xie L.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6726-34. PubMed ID: 22014749
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH, Zhang XY, Tan JJ, Chen WZ, Wang CX.
    Acta Pharmacol Sin; 2004 Jul 15; 25(7):950-8. PubMed ID: 15210071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 3D-QSAR and docking studies of aldehyde inhibitors of human cathepsin K.
    Pan X, Tan N, Zeng G, Han H, Huang H.
    Bioorg Med Chem; 2006 Apr 15; 14(8):2771-8. PubMed ID: 16377193
    [Abstract] [Full Text] [Related]

  • 11. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
    Opera TI, Waller CL, Marshall GR.
    Drug Des Discov; 1994 Jul 15; 12(1):29-51. PubMed ID: 7578806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors.
    Hu X, Stebbins CE.
    Bioorg Med Chem; 2005 Feb 15; 13(4):1101-9. PubMed ID: 15670918
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
    Latha RS, Vijayaraj R, Singam ER, Chitra K, Subramanian V.
    Chem Biol Drug Des; 2011 Sep 15; 78(3):418-26. PubMed ID: 21689378
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.